Want to see XWEL full AI Analyst Report?
XWEL Stock Chart & Stats
$1.05
$0.00(0.00%)
At close: 4:00 PM EDT
$1.05
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$0.26 - $2.20
Previous CloseN/A
Volume31.77K
Average Volume (3M)79.79K
Market Cap
$8.28M
Enterprise Value$9.70
Total Cash (Recent Filing)$16.81M
Total Debt (Recent Filing)$8.31M
Price to Earnings (P/E)―
Beta-0.11
Next Earnings
Aug 17, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-5.59
Shares Outstanding8,444,266
10 Day Avg. Volume196,854
30 Day Avg. Volume79,787
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)-0.07
Price to Sales (P/S)0.05
P/FCF Ratio-0.13
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda>-0.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Strategic Divestiture And Portfolio SimplificationSelling XpresSpa/XpresTest for ~$13M materially simplifies XWELL’s operating footprint and reduces reliance on travel-dependent airport businesses. Proceeds and fewer operating sites can improve liquidity, lower operating complexity and enable redeployment toward a clearer strategic focus over the medium term.
Gross Margin ResilienceA mid-20% gross margin indicates the core service mix can earn positive underlying gross profit. If management sustains revenue efficiency while cutting operating expenses, this margin base provides a credible path to narrowing losses and improving operating leverage over the next few quarters.
Governance And Management FocusRemoving the CEO from the board frees executive capacity to drive operations, while adding a director with capital markets and infrastructure expertise can strengthen oversight, strategic planning and access to financing. These governance moves support disciplined execution of the refocused strategy.
Bears Say
Sustained Heavy LossesExtremely large negative margins indicate core operations are not yet profitable and losses erode shareholder equity over time. Persistent deficits reduce runway, force reliance on external capital, and make it harder to invest in growth or execute strategic pivots without dilution or restructuring.
Negative Operating And Free Cash FlowMeaningful negative operating and free cash flow show the business consumes cash to run and grow. Continued cash burn limits the company’s ability to fund operations, invest in new initiatives, or weather delays in divestiture proceeds, increasing dependence on new financing or asset sales.
High Leverage With Very Thin EquityA tiny equity cushion against several million of debt leaves the balance sheet fragile. High leverage reduces financial flexibility, raises refinancing risk, and magnifies downside if revenue falls or divestiture proceeds are delayed, constraining long-term strategic options.
XWELL News
XWEL FAQ
What was XWELL’s price range in the past 12 months?
XWELL lowest stock price was $0.26 and its highest was $2.20 in the past 12 months.
What is XWELL’s market cap?
XWELL’s market cap is $8.28M.
When is XWELL’s upcoming earnings report date?
XWELL’s upcoming earnings report date is Aug 17, 2026 which is in 9 days.
How were XWELL’s earnings last quarter?
Currently, no data Available
Is XWELL overvalued?
According to Wall Street analysts XWELL’s price is currently Overvalued.
Does XWELL pay dividends?
XWELL does not currently pay dividends.
What is XWELL’s EPS estimate?
XWELL’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does XWELL have?
XWELL has 8,444,266 shares outstanding.
What happened to XWELL’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of XWELL?
Currently, no hedge funds are holding shares in XWEL
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
XWELL
XWELL Inc. functions as a health and wellness services provider, primarily operating within airports. The company delivers its diverse offerings through various brands, including XpresSpa, XpresTest, Treat, and HyperPointe. Its core services feature a range of spa treatments such as massages, nail care, and skincare, further complemented by the sale of spa, travel, and general retail merchandise. Beyond relaxation services, XWELL also manages dedicated wellness centers. These facilities provide crucial health diagnostic services, encompassing COVID-19 screening and testing, rapid tests for various communicable diseases like influenza, RSV, and different flu strains (A&B), alongside seasonal flu vaccinations and other medical diagnostic procedures. To enhance accessibility for the traveling public, the company utilizes an integrated digital platform and a tailored retail selection. As of December 31, 2021, XWELL maintained a significant global presence, with 52 spa and clinic locations spanning 24 airports across the United States, the Netherlands, and the United Arab Emirates. The organization, headquartered in New York, New York, underwent a name change in October 2022, transitioning from its former identity as XpresSpa Group, Inc. to its current designation, XWELL Inc.
Technical Analysis
Medifast
―
Regis
―
MEDIROM Healthcare Technologies
―
E-Home Household Service Holdings
―
Interactive Strength Inc
―
Ownership Overview
13.71% Insiders
1.23% Mutual Funds
<0.01% Other Institutional Investors
84.45% Public Companies and
Individual Investors